Cargando…
Trends and Challenges in Tumor Anti-Angiogenic Therapies
Excessive abnormal angiogenesis plays a pivotal role in tumor progression and is a hallmark of solid tumors. This process is driven by an imbalance between pro- and anti-angiogenic factors dominated by the tissue hypoxia-triggered overproduction of vascular endothelial growth factor (VEGF). VEGF-med...
Autores principales: | Jászai, József, Schmidt, Mirko H.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770676/ https://www.ncbi.nlm.nih.gov/pubmed/31540455 http://dx.doi.org/10.3390/cells8091102 |
Ejemplares similares
-
Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
por: Lopes-Coelho, Filipa, et al.
Publicado: (2021) -
Biomarkers in Tumor Angiogenesis and Anti-Angiogenic Therapy
por: Pircher, Andreas, et al.
Publicado: (2011) -
Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
por: Plate, Karl H., et al.
Publicado: (2012) -
Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
por: Abdalla, Ahmed M.E., et al.
Publicado: (2018) -
Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer
por: Nienhüser, Henrik, et al.
Publicado: (2017)